Placental Amniotic Epithelial Cells and Their Therapeutic Potential in Liver Diseases

As a unique source of stem cells, there is a growing interest in amniotic epithelial (AE) cells. Placenta is readily available; in fact, it is often discarded following delivery. As such, it is without the ethical concerns of embryonic stem cells. Further advantages to AE include that AE cells do no...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahan, Asli Ceren, Tahan, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291892/
https://www.ncbi.nlm.nih.gov/pubmed/25593921
http://dx.doi.org/10.3389/fmed.2014.00048
Descripción
Sumario:As a unique source of stem cells, there is a growing interest in amniotic epithelial (AE) cells. Placenta is readily available; in fact, it is often discarded following delivery. As such, it is without the ethical concerns of embryonic stem cells. Further advantages to AE include that AE cells do not demonstrate tumorigenicity upon transplantation, and are gifted with immunomodulatory and anti-inflammatory properties. Thus, AE cells have exceptional features for use as cell-based therapies for liver disease.

Ejemplares similares